McKinsey & Company to pay $650 million to settle U.S. opioid consulting probe

  • 📰 NECN
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 71%

Department Of Justice News

Business Business Latest News,Business Business Headlines

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company's consulting work…

A former top partner at McKinsey has also agreed to plead guilty to obstruction of justice in the federal probe, according to court filings Friday

A press conference will be held at 12 p.m. at the Moakley Federal Courthouse in Boston, and will be livestreamed in the video player above., citing court filings, reported Friday morning that McKinsey has agreed to pay $650 million in a five-year deferred prosecution agreement that will resolve a federal criminal probe into the company's consulting work advising Purdue Pharma on how to"turbocharge" sales of its addictive opioid drug OxyContin.

According to the criminal charging document, McKinsey"knowingly and intentionally" conspired with Purdue Pharma"and others to aid and abet the misbranding of prescription drugs," CNBC reports. Through then-partner Elling, McKinsey is also accused of"knowingly destroying and concealing records and documents with the intent" to impede the DOJ's investigation.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 20. in BUSİNESS
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Business Business Latest News, Business Business Headlines